CSIMarket
 


Syros Pharmaceuticals Inc   (SYRS)
Other Ticker:  
 

Cumulative Syros Pharmaceuticals Inc 's Working Capital Ratio for Trailing Twelve Months Period

SYRS's Working Capital Ratio for Trailing Twelve Months Period and Current Assets, Current Liabilities growth


Select the Comparisons : Select the Ratio:

SYRS Working Capital Ratio for Trailing Twelve Months Period

(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
Y / Y Current Liabilities Growth -2.32 % 28.59 % 40.92 % 0.82 % 10.08 %
Y / Y Current Assets Growth 54.77 % 64.61 % -50.62 % -48.62 % -23.51 %
Working Capital Ratio for Trailing Twelve Months Period 4.95 4.38 3.9 5.08 6.04
Total Ranking # 590 # 1016 # 1408 # 1119 # 1005
Seq. Current Liabilities Growth -19.9 % -1.29 % 41.08 % -12.43 % 5.45 %
Seq. Current Assets Growth -16.22 % 174.41 % -21.06 % -14.72 % -10.89 %


Working Capital Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Dec 31 2022
On the trailing twelve months basis Syros Pharmaceuticals Inc Current Assets average soared by 54.77% in IV. Quarter year on year, while Current Liabilities faded to $ 31 millions, this led to increase in in Syros Pharmaceuticals Inc 's Working Capital Ratio for Trailing Twelve Months Period to 4.95, Working Capital Ratio for Trailing Twelve Months Period remained below Syros Pharmaceuticals Inc average.
Working Capital Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Major Pharmaceutical Preparations industry 150 other companies have achieved higher Working Capital Ratio for Trailing Twelve Months Period than Syros Pharmaceuticals Inc . While overall ranking remained unchanged compare to previous quarter at no. .

What is Working Capital Ratio?
More about SYRS
Working Capital Ratio SYRS in the most recent quarter
Working Capital Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 151
Sector # 264
S&P 500 # 415


Working Capital Ratio for Trailing Twelve Months Period Statistics
High Average Low
9.06 5.63 3.9
(Dec 31 2017)   (Jun 30 2022)




Companies with similar average Working Capital Ratio for Trailing Twelve Months Period for 12 months ending Dec 31 2022, within Major Pharmaceutical Preparations Industry Working Capital Ratio for Trailing Twelve Months Period
Compass Pathways Plc  13.52 
Prelude Therapeutics Inc  13.38 
Viking Therapeutics Inc   13.32 
Shattuck Labs Inc   13.10 
Pliant Therapeutics Inc   12.92 
Cormedix Inc   12.83 
Savara Inc   12.63 
Acasti Pharma Inc   12.61 
Moonlake Immunotherapeutics  12.56 
Rocket Pharmaceuticals Inc   12.46 
Relmada Therapeutics Inc   12.38 
Longboard Pharmaceuticals Inc   12.33 
Acrivon Therapeutics Inc   12.31 
Ayala Pharmaceuticals Inc   12.28 
Aldeyra Therapeutics Inc   12.28 
Annexon Inc   12.25 
Moleculin Biotech Inc   12.16 
Gracell Biotechnologies Inc   12.15 
Tyme Technologies Inc.  12.11 
Dyne Therapeutics Inc   12.10 
Arcutis Biotherapeutics Inc   12.01 
United Therapeutics Corporation  11.96 
Akero Therapeutics Inc   11.96 
Avidity Biosciences Inc   11.95 
Aurinia Pharmaceuticals Inc   11.88 
Chemomab Therapeutics Ltd   11.86 
Hepion Pharmaceuticals inc   11.85 
Cytokinetics Incorporated  11.75 
Oncternal Therapeutics Inc   11.70 
Satsuma Pharmaceuticals Inc   11.66 


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

SMBK's Profile

Stock Price

SMBK's Financials

Business Description

Fundamentals

Charts & Quotes

SMBK's News

Suppliers

SMBK's Competitors

Customers & Markets

Economic Indicators

SMBK's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071